Founded in 2014 and based in Ireland, CelgenTek focuses on creating simple, targeted, effective, and personalized products to improve outcomes for patients with compromised bone. They collaborate with experts in technology development and clinical practice to design cost-efficient products supported by evidence-based research. Their implants are used in treatments such as bone augmentation in osteoporosis, infection, and avascular necrosis, providing better patient outcomes.